Skip to main content

Table 4 Incidence of major adverse events that caused discontinuation of treatment

From: The effectiveness of retreatment with peginterferon alfa and ribavirin in patients with chronic viral hepatitis C genotype 2 and 3: a prospective cohort study in Brazil

Adverse events Incidence of occurrence, n (%)
Laboratory abnormality n = 16
  Anaemia 11 (68.7)
  Thrombocytopenia/neutropenia 15 (93.7)
Death n = 8
  Acute myocardial infarction 1 (12.5)
  Pneumonia and sepsis 2 (25)
  Acute respiratory failure 2 (25)
  Encephalopathy/ascites 2 (25)
  Cause unknown 1 (12.5)